Analysts Predict Upswing for Global X Conscious Companies ETF (KRMA)
An analysis of the Global X Conscious Companies ETF (Symbol: KRMA) reveals optimism among analysts, projecting a target price that suggests potential gains for investors.
Based on a review of KRMA’s underlying assets, the implied analyst target price stands at $44.76 per unit. Currently, the ETF is trading around $40.73 per unit, indicating a projected upside of 9.89%. Notably, several of KRMA’s holdings are expected to hit higher target prices, with positive forecasts for Elevance Health Inc (Symbol: ELV), Cardinal Health, Inc. (Symbol: CAH), and Principal Financial Group Inc (Symbol: PFG). ELV, trading at $385.56, has a target price of $520.05, suggesting a significant upside of 34.88%. In comparison, CAH’s recent price of $117.42 aligns with a target of $129.75, marking a potential gain of 10.50%. Similarly, analysts anticipate PFG to achieve an average target of $87.92, which is 10.12% above its recent trading price of $79.84. Below is a chart depicting the recent performance of these stocks:
Here is a summary of the current analyst target prices:
| Name | Symbol | Recent Price | Avg. Analyst 12-Mo. Target | % Upside to Target |
|---|---|---|---|---|
| Global X Conscious Companies ETF | KRMA | $40.73 | $44.76 | 9.89% |
| Elevance Health Inc | ELV | $385.56 | $520.05 | 34.88% |
| Cardinal Health, Inc. | CAH | $117.42 | $129.75 | 10.50% |
| Principal Financial Group Inc | PFG | $79.84 | $87.92 | 10.12% |
Investors may wonder whether these targets are achievable or overly optimistic. Historical performance and recent developments in the companies and their industries will play a crucial role in determining future stock prices. A target price that significantly exceeds the current trading price may indicate strong potential, but it could also lead to adjustments if the forecasts no longer align with reality.
10 ETFs With Most Upside To Analyst Targets »
Also see:
• Victor Mashaal Stock Picks
• Funds Holding AXAS
• SURG Options Chain
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
